Nearly 17M U.S. Teens, Young Adults Eligible for GLP-1 Agonists

(Medage today) – Although about 17 million American and young adults are eligible for agonists of GLP -1 receptors for conditions such as obesity and type 2 diabetes, many were lacking in insurance or a routine place for health care, a transversal section …